James M. Frates - Mar 5, 2024 Form 4 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Signature
/s/ Joshua B. Cohen, as Attorney in Fact
Stock symbol
AMLX
Transactions as of
Mar 5, 2024
Transactions value $
-$33,560
Form type
4
Date filed
3/7/2024, 04:05 PM
Previous filing
Feb 28, 2024
Next filing
Apr 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMLX Common Stock Sale -$33.6K -1.79K -1.31% $18.73 135K Mar 5, 2024 Direct F1, F2
holding AMLX Common Stock 15.5K Mar 5, 2024 By Trust F3, F4
holding AMLX Common Stock 11.1K Mar 5, 2024 By Trust F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.62 to $18.82. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 Reflects 15,459 shares previously reported as directly beneficially owned by the Reporting Person, which were transferred to the James M. Frates 2024 Grantor Retained Annuity Trust No. 1 on February 26, 2024 for no consideration. Such transfer constituted a change in form of beneficial ownership, exempted by Rule 16a-13 under the Securities Exchange Act of 1934, as amended.
F4 Shares held by the James M. Frates 2024 Grantor Retained Annuity Trust No. 1, for which the Reporting Person serves as trustee and is the sole annuitant. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
F5 Shares held by the FRATES FAMILY 2013 IRREV TRUST, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.